Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
898.80    15.60 (1.77%)
Bid:
898.20
Ask:
899.20
Spread: 1.00 (0.111%)
Market Cap: £8.10b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

SHARE BUYBACK PROGRAMME

15 May 2025 07:00

RNS Number : 7298I
Sage Group PLC (The)
15 May 2025
 

THE SAGE GROUP PLC

SHARE BUYBACK PROGRAMME

 

Sage announces that it is extending its ongoing share buyback programme by up to £200 million.

London 15 May 2025 - The Sage Group plc ("Sage" or the "Group") today announces a share buyback programme extension for aggregate consideration of up to £200 million (the "Extended Programme") which will commence on completion of its ongoing share buyback programme for aggregate consideration of up to £400 million announced on 20 November 2024 (the "Initial Programme").

The Initial Programme is expected to end no later than 3 June 2025 (as previously announced) and, following its completion, the Extended Programme will commence. The Extended Programme is expected to end no later than 6 August 2025.

The Extended Programme is consistent with the Group's disciplined capital allocation policy, and reflects the Board's confidence in Sage's future prospects, together with Sage's strong cash generation and robust financial position. Sage continues to have considerable financial flexibility to drive the execution of its growth strategy.

Further details of the Extended Programme are set out below.

________________________________________

Enquiries

The Sage Group plc: +44 (0) 7341 479956

Caroline Xu, Group Finance

James Sandford, Investor Relations

David Ginivan, Corporate PR

FGS Global: +44 (0) 20 7251 3801

Conor McClafferty

Sophia Johnston

________________________________________

Further details of the Extended Programme

Sage has entered into non-discretionary arrangements with Morgan Stanley & Co. International plc ("Morgan Stanley") and J.P. Morgan Securities plc ("J.P. Morgan") (together, the "Brokers") in relation to the purchase by the Brokers, acting as riskless principals, of ordinary shares of Sage (the "Shares"). Morgan Stanley will conduct the first half of the Extended Programme and J.P. Morgan will conduct the second half. The Extended Programme will commence on the trading day after the Initial Programme is completed and, in any case, no later than 4 June 2025.

The Brokers will make trading decisions in relation to Shares purchased under the Extended Programme independently of, and uninfluenced by, Sage. The purpose of the Extended Programme is to reduce the share capital of Sage. The Brokers will make an on-sale of such Shares to Sage and all Shares repurchased will be cancelled.

Any purchases of Shares contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s) and will be effected within certain pre-set parameters. These arrangements are in accordance with Sage's general authority to repurchase Shares granted at its latest Annual General Meeting, Chapter 9 of the UK Listing Rules, and those provisions of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buyback programmes.

The maximum number of Shares which may currently be purchased or committed to be purchased by Sage under the Extended Programme is 81,555,354, which is the maximum number remaining as of the date of this announcement pursuant to the relevant authorities granted by shareholders at Sage's latest Annual General Meeting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFDFALEISEDI
Date   Source Headline
31st May 20194:55 pmRNSTotal Voting Rights
31st May 20199:53 amRNSDirector Declaration
30th May 20194:20 pmRNSHolding(s) in Company
30th May 20191:45 pmRNSHolding(s) in Company
20th May 20194:24 pmRNSDirector/PDMR Shareholding
20th May 20194:22 pmRNSDirector/PDMR Shareholding
17th May 20197:00 amRNSNon-Executive Director Appointment
17th May 20197:00 amRNSHalf-year Report
1st May 20191:02 pmRNSDirector Declaration
30th Apr 20193:26 pmRNSTotal Voting Rights
2nd Apr 20194:35 pmRNSDirector Declaration
2nd Apr 20198:30 amRNSUpdate on financial reporting and disclosure
29th Mar 20196:06 pmRNSTotal Voting Rights
25th Mar 20193:56 pmRNSNon-Executive Directors Changes
22nd Mar 20194:14 pmRNSHolding(s) in Company
14th Mar 20195:11 pmRNSDirector/PDMR Shareholding
5th Mar 20192:46 pmRNSDirector/PDMR Shareholding
28th Feb 20195:28 pmRNSDirector/PDMR Shareholding
28th Feb 20194:28 pmRNSTotal Voting Rights
27th Feb 20193:51 pmRNSResult of AGM
22nd Feb 20197:00 amRNSDisposal of US Payroll Outsourcing Business
14th Feb 201912:48 pmRNSProposed changes to Directors' remuneration policy
7th Feb 20195:21 pmRNSHolding(s) in Company
5th Feb 20195:03 pmRNSHolding(s) in Company
1st Feb 20191:35 pmRNSTotal Voting Rights
22nd Jan 20192:20 pmRNSNotice of AGM
17th Jan 20197:00 amRNSTrading Update
15th Jan 20191:01 pmRNSDisposal of US Payroll outsourcing business
31st Dec 20189:00 amRNSTotal Voting Rights
17th Dec 20184:23 pmRNSDirector/PDMR Shareholding
12th Dec 20182:59 pmRNSNotification of Transaction of PDMR
10th Dec 20181:00 pmRNSDirector/PDMR Shareholding
6th Dec 20185:23 pmRNSBlock listing Interim Review
6th Dec 20189:33 amRNSDirector/PDMR Shareholding
5th Dec 20184:04 pmRNSDirector/PDMR Shareholding
4th Dec 20184:33 pmRNSHolding(s) in Company
4th Dec 20187:00 amRNSAppointment of Group Chief Financial Officer
30th Nov 20185:04 pmRNSTotal Voting Rights
30th Nov 20184:59 pmRNSHolding(s) in Company
28th Nov 20183:57 pmRNSHolding(s) in Company
26th Nov 20181:24 pmRNSDirector/PDMR Shareholding
23rd Nov 20184:53 pmRNSHolding(s) in Company
21st Nov 20181:22 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSFinal Results
15th Nov 20185:32 pmRNSHolding(s) in Company
9th Nov 20184:55 pmRNSHolding(s) in Company
2nd Nov 20182:40 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSAppointment of Group Chief Executive Officer
1st Nov 20182:48 pmRNSTotal Voting Rights
25th Oct 20182:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.